These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 13311598)

  • 1. Clinical research in the pharmaceutical industry.
    RICE RM
    SD J Med Pharm; 1956 Apr; 9(4):150-3. PubMed ID: 13311598
    [No Abstract]   [Full Text] [Related]  

  • 2. Drugs, industry, and academia.
    Fitzgerald GA
    Science; 2008 Jun; 320(5883):1563. PubMed ID: 18566251
    [No Abstract]   [Full Text] [Related]  

  • 3. THE PHYSICIAN AS FINAL ARBITER?
    PAGE I
    Appl Ther; 1964 Apr; 6():293-5. PubMed ID: 14152073
    [No Abstract]   [Full Text] [Related]  

  • 4. Intellectual property. Fixing the legal framework for pharmaceutical research.
    Knowles SM
    Science; 2010 Feb; 327(5969):1083-4. PubMed ID: 20150445
    [No Abstract]   [Full Text] [Related]  

  • 5. AN INTERNATIONAL DRUG SAFEGUARD PLAN.
    FINNEY DJ
    J Chronic Dis; 1964 Jul; 17():565-81. PubMed ID: 14179659
    [No Abstract]   [Full Text] [Related]  

  • 6. THE IMPACT OF THE NEW FOOD AND DRUG LAWS AND REGULATIONS ON THE SPONSORS OF CLINICAL TRIALS.
    HEIN JW
    J Oral Ther Pharmacol; 1964 Jul; 1():85-92. PubMed ID: 14204420
    [No Abstract]   [Full Text] [Related]  

  • 7. PHYSICIAN'S LIABILITY WHEN USING NEW OR EXPERIMENTAL DRUGS.
    WASMUTH CE
    Cleve Clin Q; 1964 Apr; 31():61-73. PubMed ID: 14141716
    [No Abstract]   [Full Text] [Related]  

  • 8. THE IMPACT OF RECENT REGULATIONS OF THE FEDERAL FOOD AND DRUG ADMINISTRATION ON CLINICAL INVESTIGATION OF NEW DRUGS IN DENTISTRY: THE VIEW OF THE CLINICAL INVESTIGATOR.
    KUTSCHER AH; ZEGARELLI EV
    J Oral Ther Pharmacol; 1964 Jul; 1():79-84. PubMed ID: 14204418
    [No Abstract]   [Full Text] [Related]  

  • 9. Protect pharmaceutical innovation.
    Musselwhite LW; Andrews J
    Science; 2010 Jun; 328(5984):1354; author reply 1354-5. PubMed ID: 20538934
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharma moves ahead cautiously in China.
    Yidong G
    Science; 2005 Jul; 309(5735):735. PubMed ID: 16051788
    [No Abstract]   [Full Text] [Related]  

  • 11. Surviving the blockbuster syndrome.
    Service RF
    Science; 2004 Mar; 303(5665):1796-9. PubMed ID: 15031490
    [No Abstract]   [Full Text] [Related]  

  • 12. Productivity counts--but the definition is key.
    Mervis J
    Science; 2005 Jul; 309(5735):726. PubMed ID: 16051784
    [No Abstract]   [Full Text] [Related]  

  • 13. Justices expand rights to experiment with patented drugs.
    Pollack A
    N Y Times Web; 2005 Jun; ():C1, C8. PubMed ID: 15966121
    [No Abstract]   [Full Text] [Related]  

  • 14. Fundamental problems lie ahead in the drug discovery and commercialization process: restructuring of the pharmaceutical industry and an improved partnership with academia are required.
    Brewer GJ
    J Investig Med; 2006 Sep; 54(6):291-302. PubMed ID: 17191351
    [No Abstract]   [Full Text] [Related]  

  • 15. Medicine and the pharmaceutical industry.
    Baxter P
    Dev Med Child Neurol; 2006 Aug; 48(8):627. PubMed ID: 16836771
    [No Abstract]   [Full Text] [Related]  

  • 16. Aligning pharmaceutical innovation with medical need.
    Nathan C
    Nat Med; 2007 Mar; 13(3):304-8. PubMed ID: 17342145
    [No Abstract]   [Full Text] [Related]  

  • 17. In search of funding: the clinical investigator and the drug company; Commentary: why researchers need not be demoralized.
    Siris ES; Burrell CD
    IRB; 1983; 5(6):1-5. PubMed ID: 11649526
    [No Abstract]   [Full Text] [Related]  

  • 18. Cochrane reviews v industry supported meta-analyses: ten questions to assess bias in medical research.
    Gogol M
    BMJ; 2006 Oct; 333(7574):916-7. PubMed ID: 17068039
    [No Abstract]   [Full Text] [Related]  

  • 19. FRAME and the pharmaceutical industry.
    Balls M
    Altern Lab Anim; 2012 Dec; 40(6):295-300. PubMed ID: 23398334
    [No Abstract]   [Full Text] [Related]  

  • 20. Conflict of interest highlighted in debate on calcium-channel blockers.
    McCarthy M
    Lancet; 1998 Jan; 351(9097):191. PubMed ID: 11656736
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.